|Study Period:||2018 - 2026|
|Fastest Growing Market:||Asia Pacific|
|Largest Market:||North America|
Need a report that reflects how COVID-19 has impacted this market and its growth?
Thoracic drainage devices are designed to remove air, liquids, and some solids from the pleural space of chest. Factors such as rising demand for minimally invasive surgeries, high prevalence of cardiovascular diseases and increase in burden of spontaneous pneumothorax are driving the growth of the thoracic drainage devices market. The rise in demand for minimally invasive procedures over open surgery is triggering a high market growth rate. Also, these procedures usually provide equivalent outcomes to traditional open surgery, along with offering significant benefits, like lower risk of complications, shorter length of stay, and lesser recuperation period. Furthermore, reducing healthcare costs involved in undergoing a minimally invasive procedure when compared to the normal surgical procedure has also been an instrumental factor driving the market growth. Hence, there is increasing care provider's preference for minimally invasive procedures for a range of surgical applications which is expected to boost the demand for thoracic drainage devices worldwide.
Scope of the Report
As per the scope of the report, Thoracic drainage devices are used to drain air, fluid, or blood from the thoracic space to prevent lungs from collapsing. These devices are primarily used for disease indications such as pneumothorax, cardiac surgery procedures, and pleural effusion.
|Thoracic Drainage Systems|
|Thoracic Drainage Kits|
|Pleural Drainage Catheters|
|Oncology & Pain Management|
|Thoracic Surgery & Pulmonology|
|General Intensive Care Emergency Medicine|
|Hospitals & Clinics|
|Ambulatory Surgery Centers|
|Rest of the World|
Key Market Trends
Thoracic Surgery & Pulmonology Segment is Expected to Register a Significant Growth in the Forecast Years
By Application, the market has been segmented into Cardiac Surgery, Oncology & Pain Management, Thoracic Surgery & Pulmonology, General Intensive Care Emergency Medicine and Others. Thoracic and pulmonological disorders are quite common and the prevalence of these disorders is increasing as compared to other applications and this trend is expected to continue over the forecast period. As per the U.S. Census and the Society of Thoracic Surgery, in 2010 there were approximately 4,000 cardiothoracic surgeons who performed more than 530,000 cases. By 2030, it is expected that there will be about 3,000 cardiothoracic surgeons available to cover about 854,000 cases. The average case-load per surgeon will increase from 135 in 2010 to 299 in 2035 because of the high population growth. Thoracic drainage devices are used in the treatment of pneumothorax, pleural effusions, and empyema disorders. In addition, growing public awareness and a large patient pool also contributes to the growth of the studied market.
To understand key trends, Download Sample Report
North America leads the Thoracic Drainage Devices Market
North America is expected to lead the market, owing to high standards of healthcare infrastructure and easy availability of sophisticated technology in this region. This is primarily attributed to rising incidences of chronic diseases as well as higher healthcare expenditure in countries in the region. According to the American College of Cardiology, cardiovascular disease (CVD) accounted for 800,000 deaths in the United States in 2017 alone. Among Americans, an average of one person dies from cardiovascular disease, every 40 seconds. Europe and the Asia Pacific are followed next after North America owing to rising patient population, growth of healthcare industry and increase in the number of surgeries in the region, thus driving this market.
To understand geography trends, Download Sample Report
The major players in the thoracic drainage devices market includes ATMOS MedizinTechnik GmbH & Co. KG, Becton, Dickinson and Company, Cardinal Health, Cook Group Incorporated, Getinge AB, Sinapi Biomedical, Smiths Group plc, Teleflex Incorporated, Utah Medical Products, Inc. and Vygon SA.
In Aug 2020, the Bearpac Medical received 510(k) marketing clearance from the FDA for its Passio Pump Drainage System for home-based delivery of pleural effusion therapy.
Table of Contents
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Demand for Minimally Invasive Surgeries
4.2.2 High Prevalence of Cardiovascular Diseases
4.2.3 Increase Demand of Early Diagnosis and Treatment of Diseases
4.3 Market Restraints
4.3.1 Lack of Availability of Skilled Physicians
4.3.2 Stringent Regulatory Guidelines
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Product
5.1.1 Thoracic Drainage Systems
5.1.2 Thoracic Drainage Kits
5.1.3 Pleural Drainage Catheters
5.1.4 Trocar Drains
5.2 By Application
5.2.1 Cardiac Surgery
5.2.2 Oncology & Pain Management
5.2.3 Thoracic Surgery & Pulmonology
5.2.4 General Intensive Care Emergency Medicine
5.3 By End-User
5.3.1 Hospitals & Clinics
5.3.2 Ambulatory Surgery Centers
5.4.1 North America
188.8.131.52 United States
184.108.40.206 United Kingdom
220.127.116.11 Rest of Europe
18.104.22.168 South Korea
22.214.171.124 Rest of Asia-Pacific
5.4.4 Rest of the World
6. COMPETITIVE LANDSCAPE
*List Not Exhaustive
6.1 Company Profiles
6.1.1 ATMOS MedizinTechnik GmbH & Co. KG
6.1.2 Becton, Dickinson and Company
6.1.3 Cardinal Health
6.1.4 Cook Group Incorporated
6.1.5 Getinge AB
6.1.6 Sinapi Biomedical
6.1.7 Smiths Group plc
6.1.8 Teleflex Incorporated
6.1.9 Utah Medical Products, Inc.
6.1.10 Vygon SA
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
You can also purchase parts of this report. Do you want to check out a section wise price list?
Frequently Asked Questions
What is the study period of this market?
The Thoracic Drainage Devices Market market is studied from 2018 - 2026.
What is the growth rate of Thoracic Drainage Devices Market?
The Thoracic Drainage Devices Market is growing at a CAGR of 3.5% over the next 5 years.
Which region has highest growth rate in Thoracic Drainage Devices Market?
Asia Pacific is growing at the highest CAGR over 2021- 2026.
Which region has largest share in Thoracic Drainage Devices Market?
North America holds highest share in 2020.
Who are the key players in Thoracic Drainage Devices Market?
Becton Dickinson and Company, Cardinal Health, Cook Goup Incorporated, Getinge AB, Smith Group plc are the major companies operating in Thoracic Drainage Devices Market.